PFM Health Sciences’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

PFM Health Sciences’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-113,711	Closed	-$3.79M	–	103
2024 Q3	$3.79M	Buy	+113,711	New	+$3.92M	0.21%	56

PFM Health Sciences's LBPH Position: Q4 2024 in Review

PFM Health Sciences sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 113,711 shares — an estimated $3.79M sold.

PFM Health Sciences first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $3.79M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

PFM Health Sciences reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
PFM Health Sciences sold 113,711 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $3.79M.
PFM Health Sciences first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
PFM Health Sciences's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $3.79M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on PFM Health Sciences's 13F filing for Q4 2024, filed 14 Feb 2025.